EligibleTrials

Cross-System Effects of Acute Intermittent Hypercapnia-Based Interventions in PD

Recruiting · NCT07674264 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Florida

View the official record on ClinicalTrials.gov →
Parkinson's disease

Interventions studied

Acute intermittent hypercapnic hypoxia (AIHH)Acute intermittent hypercapnic normoxia (AIHN)

What this trial is about

Parkinsonism impairs upper airway and axial motor control, leading to disordered breathing, reduced speech volume, and ineffective cough. Symptoms are poorly addressed by current therapies. This randomized pilot trial tests whether a single session of acute intermittent hypercapnic hypoxia (AIHH) or hypercapnic normoxia (AIHN) improves upper airway and axial motor function in Parkinsonism, and explores biomarker correlates of intervention responsiveness.

Who can take part

Age range
40 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

2 locations listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.